BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26851736)

  • 21. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists.
    Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C
    Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A
    Renk DR; Skraban M; Bier D; Schulze A; Wabbals E; Wedekind F; Neumaier F; Neumaier B; Holschbach M
    Eur J Med Chem; 2021 Mar; 214():113214. PubMed ID: 33548636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A
    Zhang M; Fan S; Zhou X; Xie F; Li S; Zhong W
    Eur J Med Chem; 2019 Oct; 179():310-324. PubMed ID: 31255928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrimidin-8-on[2,1-f]theophylline-9-alkylcarboxylic acids amides as A1 and A2A adenosine receptor ligands.
    Fhid O; Pawlowski M; Jurczyk S; Muller CE; Schumacher B
    Farmaco; 2003 Jun; 58(6):439-44. PubMed ID: 12767383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor.
    Thomas A; Buccioni M; Dal Ben D; Lambertucci C; Marucci G; Santinelli C; Spinaci A; Kachler S; Klotz KN; Volpini R
    ChemMedChem; 2016 Aug; 11(16):1829-39. PubMed ID: 27037522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.
    Massink A; Holzheimer M; Hölscher A; Louvel J; Guo D; Spijksma G; Hankemeier T; IJzerman AP
    Purinergic Signal; 2015 Dec; 11(4):581-94. PubMed ID: 26482925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
    El-Tayeb A; Gollos S
    Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
    Dalpiaz A; Gessi S; Varani K; Borea PA
    Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors.
    Drabczyńska A; Müller CE; Karolak-Wojciechowska J; Schumacher B; Schiedel A; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Jul; 15(14):5003-17. PubMed ID: 17499511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
    Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
    J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins.
    Matos MJ; Hogger V; Gaspar A; Kachler S; Borges F; Uriarte E; Santana L; Klotz KN
    J Pharm Pharmacol; 2013 Nov; 65(11):1590-7. PubMed ID: 24118065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
    Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
    J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists.
    Yaziji V; Rodríguez D; Gutiérrez-de-Terán H; Coelho A; Caamaño O; García-Mera X; Brea J; Loza MI; Cadavid MI; Sotelo E
    J Med Chem; 2011 Jan; 54(2):457-71. PubMed ID: 21186795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
    Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
    Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
    Zampieri D; Laurini E; Vio L; Golob S; Fermeglia M; Pricl S; Mamolo MG
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1021-5. PubMed ID: 24486131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A
    Załuski M; Schabikowski J; Jaśko P; Bryła A; Olejarz-Maciej A; Kaleta M; Głuch-Lutwin M; Brockmann A; Hinz S; Zygmunt M; Kuder K; Latacz G; Vielmuth C; Müller CE; Kieć-Kononowicz K
    Bioorg Chem; 2020 Aug; 101():104033. PubMed ID: 32629282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure.
    Huang G; Pemp D; Stadtmüller P; Nimczick M; Heilmann J; Decker M
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4209-14. PubMed ID: 25096297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of novel xanthine derivatives as potent and selective A
    Basu S; Barawkar DA; Ramdas V; Patel M; Waman Y; Panmand A; Kumar S; Thorat S; Naykodi M; Goswami A; Reddy BS; Prasad V; Chaturvedi S; Quraishi A; Menon S; Paliwal S; Kulkarni A; Karande V; Ghosh I; Mustafa S; De S; Jain V; Banerjee ER; Rouduri SR; Palle VP; Chugh A; Mookhtiar KA
    Eur J Med Chem; 2017 Jul; 134():218-229. PubMed ID: 28415011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
    Lambertucci C; Antonini I; Buccioni M; Dal Ben D; Kachare DD; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 2009 Apr; 17(7):2812-22. PubMed ID: 19282184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
    J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.